![](/img/cover-not-exists.png)
PDB14 COST-EFFECTIVENESS OF MONO- AND COMBINATION THERAPY WITH PIOGLITAZONE COMPARED TO GLICLAZIDE IN PATIENTS WITH TYPE-2-DIABETES MELLITUS FROM A GERMAN STATUTORY HEALTH CARE PERSPECTIVE
W Schramm, K Neeser, O Mast, G Lübben, A LütkeVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65957-8
File:
PDF, 65 KB
english, 2004